Thermo Fisher Scientific Current Ratio 2012-2025 | TMO
Current and historical current ratio for Thermo Fisher Scientific (TMO) from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Thermo Fisher Scientific current ratio for the three months ending September 30, 2025 was 1.50.
| Thermo Fisher Scientific Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $22.30B | $14.89B | 1.50 |
| 2025-06-30 | $24.58B | $12.72B | 1.93 |
| 2025-03-31 | $23.38B | $13.17B | 1.78 |
| 2024-12-31 | $22.14B | $13.33B | 1.66 |
| 2024-09-30 | $23.78B | $14.60B | 1.63 |
| 2024-06-30 | $25.48B | $14.77B | 1.73 |
| 2024-03-31 | $23.64B | $13.94B | 1.70 |
| 2023-12-31 | $24.59B | $14.01B | 1.76 |
| 2023-09-30 | $23.09B | $14.16B | 1.63 |
| 2023-06-30 | $20.00B | $14.11B | 1.42 |
| 2023-03-31 | $20.21B | $15.88B | 1.27 |
| 2022-12-31 | $25.23B | $17.01B | 1.48 |
| 2022-09-30 | $19.30B | $11.12B | 1.74 |
| 2022-06-30 | $18.10B | $11.00B | 1.65 |
| 2022-03-31 | $18.78B | $12.07B | 1.56 |
| 2021-12-31 | $20.11B | $13.44B | 1.50 |
| 2021-09-30 | $24.72B | $7.75B | 3.19 |
| 2021-06-30 | $19.26B | $6.93B | 2.78 |
| 2021-03-31 | $17.69B | $7.00B | 2.53 |
| 2020-12-31 | $21.96B | $10.30B | 2.13 |
| 2020-09-30 | $18.23B | $6.23B | 2.93 |
| 2020-06-30 | $15.78B | $6.01B | 2.62 |
| 2020-03-31 | $12.74B | $5.50B | 2.32 |
| 2019-12-31 | $11.89B | $6.20B | 1.92 |
| 2019-09-30 | $10.51B | $5.84B | 1.80 |
| 2019-06-30 | $11.22B | $7.51B | 1.50 |
| 2019-03-31 | $9.94B | $5.90B | 1.69 |
| 2018-12-31 | $10.63B | $6.15B | 1.73 |
| 2018-09-30 | $9.57B | $5.20B | 1.84 |
| 2018-06-30 | $9.47B | $5.98B | 1.58 |
| 2018-03-31 | $9.59B | $7.07B | 1.36 |
| 2017-12-31 | $9.42B | $7.05B | 1.34 |
| 2017-09-30 | $8.84B | $7.03B | 1.26 |
| 2017-06-30 | $7.45B | $5.08B | 1.47 |
| 2017-03-31 | $7.25B | $5.30B | 1.37 |
| 2016-12-31 | $7.02B | $4.87B | 1.44 |
| 2016-09-30 | $8.20B | $5.26B | 1.56 |
| 2016-06-30 | $6.33B | $5.53B | 1.15 |
| 2016-03-31 | $6.54B | $6.32B | 1.03 |
| 2015-12-31 | $5.74B | $4.15B | 1.39 |
| 2015-09-30 | $6.03B | $5.74B | 1.05 |
| 2015-06-30 | $6.24B | $6.10B | 1.02 |
| 2015-03-31 | $6.18B | $6.86B | 0.90 |
| 2014-12-31 | $6.54B | $5.35B | 1.22 |
| 2014-09-30 | $5.72B | $6.22B | 0.92 |
| 2014-06-30 | $5.94B | $6.24B | 0.95 |
| 2014-03-31 | $7.31B | $5.39B | 1.36 |
| 2013-12-31 | $9.88B | $3.13B | 3.16 |
| 2013-09-30 | $6.21B | $2.45B | 2.53 |
| 2013-06-30 | $5.64B | $2.36B | 2.39 |
| 2013-03-31 | $5.14B | $2.30B | 2.23 |
| 2012-12-31 | $4.84B | $2.09B | 2.31 |
| 2012-09-30 | $4.95B | $2.52B | 1.96 |
| 2012-06-30 | $4.67B | $2.70B | 1.73 |
| 2012-03-31 | $4.77B | $2.85B | 1.68 |
| 2011-12-31 | $4.82B | $3.11B | 1.55 |
| 2011-09-30 | $4.74B | $2.79B | 1.70 |
| 2011-06-30 | $5.01B | $1.82B | 2.76 |
| 2011-03-31 | $6.19B | $4.15B | 1.49 |
| 2010-12-31 | $4.14B | $1.71B | 2.42 |
| 2010-09-30 | $4.17B | $1.77B | 2.36 |
| 2010-06-30 | $4.35B | $1.62B | 2.69 |
| 2010-03-31 | $4.53B | $1.78B | 2.55 |
| 2009-12-31 | $4.53B | $1.64B | 2.76 |
| 2009-09-30 | $4.80B | $1.59B | 3.01 |
| 2009-06-30 | $4.47B | $1.52B | 2.93 |
| 2009-03-31 | $4.52B | $1.50B | 3.01 |
| 2008-12-31 | $4.35B | $1.54B | 2.82 |
| 2008-09-30 | $4.44B | $1.84B | 2.42 |
| 2008-06-30 | $4.30B | $1.88B | 2.29 |
| 2008-03-31 | $3.99B | $1.91B | 2.09 |
| 2007-12-31 | $3.67B | $1.90B | 1.93 |
| 2007-09-30 | $3.91B | $1.63B | 2.40 |
| 2007-06-30 | $4.01B | $1.60B | 2.50 |
| 2007-03-31 | $3.75B | $1.80B | 2.09 |
| 2006-12-31 | $3.66B | $2.15B | 1.70 |
| 2006-09-30 | $1.28B | $0.72B | 1.77 |
| 2006-06-30 | $1.28B | $0.78B | 1.63 |
| 2006-03-31 | $1.38B | $0.72B | 1.92 |
| 2005-12-31 | $1.35B | $0.79B | 1.71 |
| 2005-09-30 | $1.26B | $0.73B | 1.73 |
| 2005-06-30 | $1.24B | $0.79B | 1.57 |
| 2005-03-31 | $1.49B | $0.55B | 2.71 |
| 2004-12-31 | $1.47B | $0.58B | 2.54 |
| 2004-09-30 | $1.37B | $0.63B | 2.16 |
| 2004-06-30 | $1.41B | $0.70B | 2.03 |
| 2004-03-31 | $1.45B | $0.69B | 2.12 |
| 2003-12-31 | $1.40B | $0.69B | 2.04 |
| 2003-09-30 | $1.30B | $0.59B | 2.18 |
| 2003-06-30 | $1.44B | $0.80B | 1.80 |
| 2003-03-31 | $1.56B | $0.83B | 1.87 |
| 2002-12-31 | $1.77B | $1.10B | 1.61 |
| 2002-09-30 | $1.78B | $1.14B | 1.57 |
| 2002-06-30 | $1.90B | $1.08B | 1.76 |
| 2002-03-31 | $2.05B | $1.11B | 1.84 |
| 2001-12-31 | $1.97B | $1.14B | 1.72 |
| 2001-09-30 | $2.32B | $0.70B | 3.32 |
| 2001-06-30 | $2.43B | $0.66B | 3.67 |
| 2001-03-31 | $2.32B | $0.72B | 3.21 |
| 2000-12-31 | $2.47B | $0.73B | 3.38 |
| 2000-09-30 | $2.34B | $0.74B | 3.16 |
| 2000-06-30 | $2.26B | $0.89B | 2.54 |
| 2000-03-31 | $2.69B | $1.06B | 2.54 |
| 1999-12-31 | $2.52B | $1.07B | 2.36 |
| 1999-09-30 | $3.02B | $1.42B | 2.13 |
| 1999-06-30 | $2.94B | $1.24B | 2.37 |
| 1999-03-31 | $3.07B | $1.23B | 2.50 |
| 1998-12-31 | $3.30B | $1.14B | 2.90 |
| 1998-09-30 | $3.27B | $1.12B | 2.91 |
| 1998-06-30 | $3.56B | $1.04B | 3.42 |
| 1998-03-31 | $3.37B | $1.05B | 3.19 |
| 1997-12-31 | $3.09B | $1.09B | 2.83 |
| 1997-09-30 | $3.07B | $1.01B | 3.04 |
| 1997-06-30 | $2.81B | $1.01B | 2.77 |
| 1997-03-31 | $2.97B | $1.13B | 2.63 |
| 1996-12-31 | $3.13B | $0.91B | 3.43 |
| 1996-09-30 | $2.95B | $0.93B | 3.18 |
| 1996-06-30 | $2.88B | $0.93B | 3.11 |
| 1996-03-31 | $2.67B | $0.96B | 2.79 |
| 1995-12-31 | $2.02B | $0.72B | 2.83 |
| 1995-09-30 | $1.90B | $0.63B | 3.02 |
| 1995-06-30 | $1.79B | $0.61B | 2.93 |
| 1995-03-31 | $1.69B | $0.57B | 2.97 |
| 1994-12-31 | $1.71B | $0.56B | 3.05 |
| 1994-09-30 | $1.62B | $0.49B | 3.32 |
| 1994-06-30 | $1.60B | $0.48B | 3.34 |
| 1994-03-31 | $1.25B | $0.47B | 2.65 |
| 1993-12-31 | $1.25B | $0.42B | 2.99 |
| 1993-09-30 | $1.18B | $0.39B | 3.07 |
| 1993-06-30 | $0.82B | $0.36B | 2.28 |
| 1993-03-31 | $0.80B | $0.35B | 2.27 |
| 1992-12-31 | $0.83B | $0.33B | 2.54 |
| 1992-09-30 | $0.78B | $0.32B | 2.46 |
| 1992-06-30 | $0.68B | $0.23B | 2.96 |
| 1992-03-31 | $0.70B | $0.21B | 3.36 |
| 1991-12-31 | $0.69B | $0.23B | 3.04 |
| 1991-09-30 | $0.65B | $0.21B | 3.04 |
| 1991-06-30 | $0.56B | $0.22B | 2.55 |
| 1991-03-31 | $0.55B | $0.23B | 2.44 |
| 1990-12-31 | $0.50B | $0.26B | 1.94 |
| 1990-09-30 | $0.49B | $0.24B | 2.04 |
| 1990-06-30 | $0.45B | $0.24B | 1.86 |
| 1990-03-31 | $0.39B | $0.13B | 2.96 |
| 1989-12-31 | $0.45B | $0.17B | 2.63 |
| 1989-09-30 | $0.37B | $0.11B | 3.39 |
| 1989-06-30 | $0.34B | $0.12B | 2.79 |
| 1989-03-31 | $0.32B | $0.10B | 3.22 |
| 1988-12-31 | $0.33B | $0.12B | 2.69 |
| 1988-09-30 | $0.31B | $0.11B | 2.84 |
| 1988-06-30 | $0.28B | $0.10B | 2.71 |
| 1988-03-31 | $0.28B | $0.10B | 2.81 |
| 1987-12-31 | $0.30B | $0.10B | 3.11 |
| 1987-09-30 | $0.29B | $0.08B | 3.80 |
| 1987-06-30 | $0.28B | $0.08B | 3.74 |
| 1987-03-31 | $0.19B | $0.07B | 2.70 |
| 1986-12-31 | $0.19B | $0.08B | 2.56 |
| 1985-12-31 | $0.13B | $0.06B | 2.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $233.627B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $196.001B | 76.68 |
| IDEXX Laboratories (IDXX) | United States | $56.733B | 56.34 |
| Edwards Lifesciences (EW) | United States | $48.223B | 32.33 |
| IQVIA Holdings (IQV) | United States | $41.102B | 22.92 |
| Alcon (ALC) | Switzerland | $39.514B | 26.70 |
| Mettler-Toledo (MTD) | United States | $30.348B | 35.51 |
| DexCom (DXCM) | United States | $27.184B | 37.47 |
| STERIS (STE) | Ireland | $25.935B | 26.77 |
| Waters (WAT) | United States | $23.414B | 30.96 |
| Coloplast (CLPBY) | Denmark | $20.103B | 34.31 |
| Hologic (HOLX) | United States | $16.754B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.523B | 0.00 |
| Globus Medical (GMED) | United States | $12.375B | 25.97 |
| Penumbra (PEN) | United States | $12.275B | 86.34 |
| Masimo (MASI) | United States | $7.435B | 23.82 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.998B | 0.00 |
| TransMedics (TMDX) | United States | $4.851B | 57.47 |
| Teleflex (TFX) | United States | $4.554B | 7.26 |
| Veracyte (VCYT) | United States | $3.356B | 38.24 |
| LivaNova (LIVN) | United Kingdom | $3.323B | 17.95 |
| Integer Holdings (ITGR) | United States | $2.968B | 13.93 |
| Elekta AB (EKTAY) | Sweden | $2.412B | 22.57 |
| Alphatec Holdings (ATEC) | United States | $2.369B | 0.00 |
| Artivion (AORT) | United States | $2.013B | 92.39 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| Nihon Kohden (NHNKY) | Japan | $1.974B | 17.23 |
| PROCEPT BioRobotics (PRCT) | United States | $1.753B | 0.00 |
| AxoGen (AXGN) | United States | $1.421B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.415B | 0.00 |
| IRadimed (IRMD) | United States | $1.292B | 61.53 |
| OPKO Health (OPK) | United States | $0.998B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.976B | 5.29 |
| Pulse Biosciences (PLSE) | United States | $0.969B | 0.00 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.748B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.670B | 38.96 |
| Alpha Tau Medical (DRTS) | Israel | $0.636B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 10.99 |
| Mesa Laboratories (MLAB) | United States | $0.479B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.422B | 0.00 |
| RxSight (RXST) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 61.06 |
| Sight Sciences (SGHT) | United States | $0.364B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.327B | 2.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.186B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.145B | 0.00 |
| Solana (HSDT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Hyperfine (HYPR) | United States | $0.120B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.28 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |